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Bacterial lipoproteins are membrane proteins with diverse functions. They provide structural 
integrity to the cell wall and participate in nutrient uptake, sporulation, adhesion and 
antibiotic resistance. Importantly they provoke host immune responses by the interaction of 
their lipids with Toll-like receptor 2 and many elicit protective antibody responses. 
Unsurprisingly, lipoproteins are emerging as promising vaccines. To this end, the 
lipoproteome of Clostridium difficile, was investigated.  
Lipoproteins possess an N terminal signal peptide comprising positively charged initial 
residues, a hydrophobic region and the lipobox ending in an invariant cysteine. Following 
export from the cytoplasm across the cytoplasmic membrane, lipoprotein diacylglyceryl 
transferase (Lgt) attaches two fatty acids to this cysteine and signal peptidase II (Lsp) 
cleaves off the signal peptide directly upstream of the cysteine. In Gram positive bacteria, 
lipoproteins remain anchored to this membrane by their lipid domain and some traverse the 
cell wall resulting in exposure at the cell surface.  
Not all lipoproteins can be identified by currently available gene mining approaches so in 
addition, an unconventional approach was adopted. Lipobox consensus sequences were 
used as query inputs in BLASTp analysis against the C. difficile 630 genome. Those located 
towards the N terminus of the protein sequence were further analysed for the presence of 
the remainder of the signal peptide which was confirmed by the DOLOP algorithm. This led 
to the new identification of 8 putative lipoproteins, 2 of which are highly probable. Our 
analysis further showed extensive plasticity in C. difficile for the lipobox and 14% of the 79 
lipoproteins identified revealed a signal peptide of more than one length. A selection of these 
lipoproteins will be characterised experimentally and their vaccine candidacy tested. 
 
 
